HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmetics Industry Vulnerable As Nagoya Protocol Enters Into Force

This article was originally published in The Rose Sheet

Executive Summary

Launching in October, the Nagoya Protocol on Access and Benefit Sharing and related legislation emerging around the globe will focus regulatory scrutiny on companies researching and developing plants and other genetic resources for commercial applications. The cosmetics industry could be a ready target, an expert says, urging firms to assess their supply chains and ensure that necessary ABS agreements are in place.

You may also be interested in...

Conducting Plant Material R&D? Nagoya Pact Requires ABS Due Diligence

The Nagoya Protocol on Access and Benefit Sharing comes into force this fall, as will an EU regulation instituting checks to ensure that firms conducting R&D on genetic resources are compliant with ABS laws in provider countries. With other countries around the globe developing their own legislation under the international treaty, cosmetics firms large and small must exercise due diligence, assessing their ingredient use and supply chains to avoid penalties and reputational damage.

Sold! Tengram Leaves High Ridge Auction With Iconic Brands Including Zest, Alberto VO5

Subject to the approval of a federal bankruptcy court presiding over High Ridge Brands’ Chapter 11 case, private equity firm Tengram will add a raft of personal cleansing and hair-care brands to its portfolio while bringing back former High Ridge CEO James Daniels to head up the collection’s rejuvenation.

EU Scientific Committee Reviewing Three UV Filters Against Endocrine-Disrupting Concerns

The European Commission issued requests on 4 February for updated opinions from the Scientific Committee on Consumer Safety on octocrylene, homosalate and benzophenone-3, in light of concerns that led to their listing in 2019 as “higher priority” substances used in cosmetics with endocrine-disrupting potential.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts